MC
Mason Carrico Stephens & Co. Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
NeoGenomics
NEO
$1.03B
| $7.98 | $11 |
38%
upside
| Overweight | 5 days ago |
|
2 |
2
Natera
NTRA
$23.1B
| $168.02 | $183 |
9%
upside
| Overweight | 23 days ago |
|
3 |
3
Vericel Corp
VCEL
$1.72B
| $34.05 | $67 |
97%
upside
| Overweight | 2 months ago |
|
4 |
4
Illumina
ILMN
$15.7B
| $98.93 | $105 |
6%
upside
| Overweight | 3 months ago |
|
5 |
5
Pacific Biosciences
PACB
$381M
| $1.27 | $1.80 |
42%
upside
| Overweight | 3 months ago |
|
6 |
6
10x Genomics
TXG
$1.74B
| $13.96 | $14 |
0%
upside
| Overweight | 3 months ago |
|
7 |
7
Hologic
HOLX
$14.8B
| $66.76 | $70 |
5%
upside
| Overweight | 3 months ago |
|
8 |
8
CareDx
CDNA
$736M
| $13.82 | $40 |
189%
upside
| Overweight | 4 months ago |
|
9 |
9
Glaukos
GKOS
$5.39B
| $93.94 | $115 |
22%
upside
| Overweight | 4 months ago |
|
10 |
10
Veracyte
VCYT
$2.55B
| $32.43 | $45 |
39%
upside
| Overweight | 5 months ago |
|
11 |
11
Guardant Health
GH
$7.5B
| $60.13 | $55 |
9%
downside
| Overweight | 5 months ago |
|
12 |
12
Cytek Biosciences
CTKB
$511M
| $4.02 | $6 |
49%
upside
| Overweight | 5 months ago |
|
13 |
13
STAAR Surgical
STAA
$1.38B
| $27.94 | $17 |
39%
downside
| Equal-Weight | 5 months ago |
|
14 |
14
Establishment Labs
ESTA
$1.13B
| $39.03 | $52 |
33%
upside
| Overweight | 6 months ago |
|
15 |
15
Myriad Genetics
MYGN
$615M
| $6.61 | $20 |
203%
upside
| Equal-Weight | 7 months ago |
|
16 |
16
Castle Biosciences
CSTL
$683M
| $23.56 | $41 |
74%
upside
| Overweight | 8 months ago |
|